Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/24/2025

Hypernatremia Management and Considerations

Definition and Pathophysiology

  • Hypernatremia is defined as a serum sodium concentration greater than 145 mmol/L, representing a state of relative water deficit compared to total body sodium 1
  • In chronic hypernatremia (>48 hours), brain cells generate idiogenic osmoles to protect against volume loss, making rapid correction dangerous as it can cause cerebral edema 1

Special Population Considerations

  • In very low birth weight infants, hypernatremia is often iatrogenic, resulting from incorrect replacement of transepidermal water loss, inadequate water intake, or excessive sodium intake during the transition phase 1
  • Rapid correction can induce cerebral edema, seizures, and neurological injury; a reduction rate of 10-15 mmol/L/24h is recommended 1, 2
  • Older adults are particularly vulnerable to hypernatremia due to diminished thirst perception, reduced renal concentrating ability, increased comorbidities, and higher use of diuretic medications 4
  • Water homeostasis is more vulnerable with tendency toward both hypo- and hypervolemia in elderly patients 4
  • Hypophosphatemia during refeeding can provoke acute psychotic changes and delirium, especially when glucose infusion causes rapid intracellular shifts 4

Treatment and Correction

  • Overly rapid correction of chronic hypernatremia (>48 hours) can cause cerebral edema and seizures; correction should not exceed 10-15 mmol/L per 24 hours or 0.5 mmol/L per hour 1, 2
  • Using normal saline (0.9% NaCl) as primary rehydration fluid in hypernatremic patients worsens the condition due to its high sodium content (154 mmol/L) 2
  • Salt supplementation is contraindicated in patients with secondary nephrogenic diabetes insipidus and hypernatremic dehydration 3

Patient Conditions and Considerations

  • Some neonates with salt-wasting conditions (Bartter syndrome types 1 and 2) may develop secondary nephrogenic diabetes insipidus, creating a therapeutic dilemma where salt supplementation worsens polyuria and risks hypernatremic dehydration 3